南方医院药学部副主任，硕士生导师，药理学博士，主任药师，美国Baylor医学院访问学者。
担任中国优生优育协会临床药学专业委员会副主任委员，广东省医院管理评价质控中心医院等级评审员，广东省肝脏病学会临床药学专业委员会主任委员，广东省药学会静脉用药调配专业委员会副主任委员，广东省药学会肿瘤用药专家委员会副主任委员，广东省药理学会科学普及专业委员会副主任委员，广东省药学会药学科普专业委员会副主任委员，发表SCI论文10余篇，先后承担省、市课题10余项，长期从事抗肿瘤药物药理学和抗炎免疫药理学研究。
一、近三年发表的论文
1. 戴美琴，蔡茁，陈娜娜，李金州，温嘉泳，谭丽转，郭丹*。苦参碱通过调控β-catenin信号通路抑制肝癌细胞干性。南方医科大学学报，2019,39（10）：1239-1245
2. Wang JH, Zhao LF, Wang HF, Wen YT,Jiang KK, Mao XM, Zhou ZY, Kai Tai Yao KT, Geng QS, Guo D*，Huang ZX*.GenCLiP 3: mining human genes' functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics, 2019, 1-3
3. Dai MQ, Chen NN, Li JZ, Tan LZ, Li XJ, Lei LS, Guo D*. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Phytomedicine, 2021, 87: 153580
4. Xun TR, Lin ZF, Zhan X, Song SL, Mo LQ, Feng HX, Yang Q, Guo D*, Yang XX*. Advanced oxidation protein products upregulate efflux transporterexpression and activity through activation of the Nrf-2-mediated signaling pathway in vitro and in vivo. European Journal of Pharmaceutical Sciences, 2020,149:105342
5. Huang WQ, Chen JX, Liu XH, Liu XM, Duan SY, Chen LX, Liu XT, Lan JW, Zou Y, Guo D*, Zhou J*. MIER3 induces epithelial-mesenchymal transition and promotes breastcancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.Experimental Cell Research, 2021, 406: 112722
6. Luo BY*, Zhou J*, Guo D*, Yang Q, Tian Q, Cai DP, Zhou RM, Xu ZZ, Wang HJ, Chen SY, Xie WB. Methamphetamine induces thoracic aortic aneurysm/dissection through C/EBPβ, Molecular Basis of Disease,2022(1868):166447
7.Long XL, Liu XH, Deng T, Chen JX, Lan JW, Zhang SJ, Zhou Mi, Guo D*, Zhou J*. LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis, J Exp Clin Cancer Res , 2023; 42(1): 33